Home  >  News
you can get e-magazine links on WhatsApp.Click here
  Diurnal inks pact with ExCEEd Orphan for marketing of Alkindi & Efmodyin Central and Eastern European countries,   October 16, 2021
  Dr Reddy's Labs launches generic BiCNU in US market,   October 16, 2021
  Helsinn grants Fosun Pharma license to distribute, promote & market, Aloxi, Akynzeo oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR,   October 13, 2021
  Elixirgen Therapeutics inks licensing pact to commercialize its self-replicating RNA vaccine for Covid-19,   October 11, 2021
  Glenmark Pharma launches Tavulus for COPD treatment in Spain,   October 11, 2021
  Starpharma inks sales & distribution agreement with ADMENTA Italia Group for Viraleze antiviral nasal spray,   October 09, 2021
  Biocon expands generic formulations portfolio with launch of everolimus tablets in US,   October 04, 2021
  Natco Pharma’s partner Breckenridge Pharma launches generic Afinitor in US market,   October 01, 2021
  Takeda collaborates with JCR Pharma to commercialize JR-141 to treat Hunter syndrome,   October 01, 2021
  EMA appoints rapporteur & co-rapporteur as part of the process related to Humanigen’s plan to submiy MAA for lenzilumab to treat Covid-19,   September 30, 2021
  Glenmark Pharma receives marketing approval for FDC nasal spray, Ryaltris in 13 countries across EU & UK,   September 30, 2021
  Doceree introduces opti-channel marketing for pharma sector in India,   September 28, 2021
  Eli Lilly issues voluntary nationwide recall of?one lot of Glucagon Emergency Kit due?to loss of potency,   September 27, 2021
  Baxter launches US FDA approved ready-to-use cardiovascular medicine Norepinephrine in premix formulation,   September 25, 2021
  Zydus Cadila gets US FDA marketing approval for apremilast tablets,   September 24, 2021
  UK MHRA grants marketing authorization to Rhythm Pharma’s Imcivree to treat obesity and hyperphagia,   September 23, 2021
  Calliditas announces EMA committee to continue assess of MAA for Nefecon under standard procedure assessment timelines,   September 18, 2021
  Diurnal Group launches Efmody in UK to treat patients with rare condition congenital adrenal hyperplasia,   September 16, 2021
  Lupin launches generic Duexis tablets,   September 15, 2021
  Alnylam seeks European marketing approval for vutrisiran to treat hereditary ATTR amyloidosis with polyneuropathy,   September 15, 2021

Copyright © 2016 Saffron Media Pvt. Ltd |